A Phase 1, Single-Blind, Placebo Controlled, Sequential Design Study to Evaluate the Drug Interaction Potential Between Glimepiride and TAK-875 in Subjects With Type 2 Diabetes Mellitus.
Phase of Trial: Phase I
Latest Information Update: 09 Jun 2013
At a glance
- Drugs Fasiglifam (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 12 Sep 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
- 13 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Dec 2011 New trial record